Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Hashimoto

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Oncology|September 9, 2020
Diagnostic Capability of Cerebrospinal Fluid-Placental Alkaline Phosphatase Value in Intracranial Germ Cell TumorMichinari Okamoto, Shigeru Yamaguchi, Yukitomo Ishi, et al.
Journal of Neurosurgery. Case Lessons|September 20, 2023
Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative caseMakoto Mizushima, Michinari Okamoto, Shigeru Yamaguchi, et al.
Radiation Oncology (London, England)|December 14, 2019
The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapyYasuhiro Dekura, Kentaro Nishioka, Takayuki Hashimoto, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2005
Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high- and low-response tumorsKiyoshi Ohara, Akinori Oki, Yumiko Oishi Tanaka, et al.
Japanese Journal of Clinical Oncology|April 16, 2013
Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinomaKen Kato, Takako Eguchi Nakajima, Yoshinori Ito, et al.
Journal of Applied Clinical Medical Physics|January 19, 2022
Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancerHiroshi Tamura, Keiji Kobashi, Kentaro Nishioka, et al.
Physics and Imaging in Radiation Oncology|October 25, 2021
A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancerTakaaki Yoshimura, Kentaro Nishioka, Takayuki Hashimoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry studyMasaki Nakamura, Kazushi Maruo, Masao Murakami, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2026
Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer"Hiromitsu Iwata, Masao Murakami, Kazushi Maruo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2011
Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beamNobuyoshi Fukumitsu, Toshiyuki Okumura, Masashi Mizumoto, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Oncology|September 9, 2020
Diagnostic Capability of Cerebrospinal Fluid-Placental Alkaline Phosphatase Value in Intracranial Germ Cell TumorMichinari Okamoto, Shigeru Yamaguchi, Yukitomo Ishi, et al.
Journal of Neurosurgery. Case Lessons|September 20, 2023
Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative caseMakoto Mizushima, Michinari Okamoto, Shigeru Yamaguchi, et al.
Radiation Oncology (London, England)|December 14, 2019
The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapyYasuhiro Dekura, Kentaro Nishioka, Takayuki Hashimoto, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2005
Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high- and low-response tumorsKiyoshi Ohara, Akinori Oki, Yumiko Oishi Tanaka, et al.
Japanese Journal of Clinical Oncology|April 16, 2013
Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinomaKen Kato, Takako Eguchi Nakajima, Yoshinori Ito, et al.
Journal of Applied Clinical Medical Physics|January 19, 2022
Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancerHiroshi Tamura, Keiji Kobashi, Kentaro Nishioka, et al.
Physics and Imaging in Radiation Oncology|October 25, 2021
A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancerTakaaki Yoshimura, Kentaro Nishioka, Takayuki Hashimoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry studyMasaki Nakamura, Kazushi Maruo, Masao Murakami, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2026
Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer"Hiromitsu Iwata, Masao Murakami, Kazushi Maruo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2011
Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beamNobuyoshi Fukumitsu, Toshiyuki Okumura, Masashi Mizumoto, et al.
Pageof 12